DUBLIN, Feebarwari 24, 2022–(WIRE GANACSIGA)–Warbixinta "Shiinaha ee Vitro Diagnostics Market, Size, Saadaasha 2022-2027, Isbeddellada Warshadaha, Kobaca, Wadaagga, Saamaynta COVID-19, Falanqaynta Shirkadda" ayaa lagu daray ResearchAndMarkets. com soo bandhigay.
Suuqa Shiinaha ee In-vitro Diagnostics (IVD) wuxuu udub dhexaad u yahay bixinta daryeelka caafimaadka adduunka oo dhan, waxaana lagu qiyaasaa inuu yahay US $ 18.9 bilyan sanadka 2027. Ka sokow, Shiinaha waa suuqa shaybaarka caafimaad ee ugu weyn Aasiya waana mid ka mid ah kuwa ugu dhaqsaha badan adduunka. goobaha caafimaadka.
Waxaa cajiib ah, sanadihii la soo dhaafay, heerka kobaca dhaqaalaha Shiinaha wuxuu ahaa mid cajiib ah, taasoo dejisay kobac faa'iido leh oo wax soo saar ah sanadkii.Intaa waxaa dheer, muuqaalka Shiinaha ee IVD waxaa taariikh ahaan gacanta ku haya bixiyeyaasha caalamiga ah ee waaweyn, oo leh qalab gudaha ah oo yar iyo alaab-qeybiyeyaal qiimeeya.Dheeraad ah, raadinta isbeddel, shirkadda bilawga ah waxay u aragtaa horumarinta goobaha ogaanshaha iyo imtixaannada soo bandhigaya ogaanshaha degdega ah ee calaamado badan oo dhiig ku salaysan.
Warshadaha In-Vitro Diagnostics ee Shiinaha ayaa ku fidaya laba-lambar CAGR oo ah 16.9% inta lagu jiro 2021-2027
Warshadaha IVDs ee Shiinaha ayaa sii kordhaya sannado waxayna leeyihiin cilmi-baaris caalami ah oo muhiim ah iyo saldhig wax soo saar.Shiinaha, waxaa jira baahi caafimaad oo adag oo loogu talagalay horumarinta joogtada ah ee shirkadaha IVD.Si kastaba ha noqotee, shuruudaha ogaanshaha cusub ayaa si joogto ah u soo baxaya, oo u baahan shaybaarro caafimaad si ay u fuliyaan mashruucyo tijaabo ah oo dheeri ah iyo shirkadaha IVD si ay u sameeyaan tignoolajiyada iyo alaabada cusub.Intaa waxaa dheer, iyada oo heerarka nolosha ee dadka Shiinaha oo soo hagaagay iyo xawaaraha da'da ee dadka Shiinaha, baahida loo qabo maareynta caafimaadka qoyska ayaa sii kordheysa;wadadani waxay markaa noqon doontaa barta kobaca ee muhiimka ah ee ganacsiyada ogaanshaha vitro.
Sidee Coronavirus Uga Faa'ideeyay Shiinaha Isbeddellada Kobaca Suuqa Cilmi-baarista In-Vitro
COVID-19 waxa uu sii dardar galiyay kobaca warshadaha ogaanshaha In-vitro ee Shiinaha.Sida Shiinuhu u ilaalinayo eber siyaasadda COVID, si loo gaaro tirada badan ee baaritaanka PCR iyo baarista Antigen-ka ee degdegga ah ayaa loo baahan yahay in la sameeyo.Sababo la xiriira kala duwanaanshaha COVID sida Alpha, Beta, Gamma Delta, Delta Plus, iyo dhawaan Omnicorn, tijaabada PCR iyo tijaabooyinka Antigen ee Degdegga ah waxay ku sii socon doonaan inay dhacaan tiro aad u badan.Marka loo eego daabacaha, Cabirka Suuqa In-Vitro Diagnostics Market ee Shiinaha wuxuu ahaa $ 7.4 bilyan sanadka 2021.
Qaybta Baadhista Molecular Diagnostics waxay diiwaangelisaa korriin xooggan
Warbixinta, suuqa ayaa loo kala saaray kiimiko caafimaad, Immunoassay, Diagnostic Molecular Diagnostic, Microbiology, Hematology, iyo Self-Monitoring of Blood Glucose (SMBG), Tijaabada Daryeelka (POCT), iyo xinjirowga.IVD, mid ka mid ah horumarka ugu qiimaha badan ayaa ahaa qaabka qalabka lagu ogaanayo molecular.Sida ku cad falanqaynta, falcelinta silsiladda polymerase waa safka hore ee ugu caansan ee ogaanshaha molecular.
Ka sokow, alaabada PCR-ga-waqtiga-dhabta ah waxay si isku mid ah u ogaadaan fayrasyada, bakteeriyada, fangaska, iyo dulinnada, taasoo u oggolaanaysa shaybaarada molecular inay hoos u dhigaan kharashyada oo ay keenaan natiijooyin wanaagsan oo lagu ogaanayo molecular.Waxaa cajiib ah, tijaabooyinka ogaanshaha molecular waxaa loo isticmaalaa in lagu ogaado taxane gaar ah oo DNA ama RNA ah (ay ku jiraan hal nucleotide polymorphism (SNP), tirtirid, dib u habeyn, galin, iyo kuwo kale) kuwaas oo laga yaabo ama laga yaabo inay la xiriiraan cudur kasta.
Ciyaartoyda muhiimka ah ee Suuqa IVD ee Shiinaha
Shirkadaha waaweyn ee caalamiga ah ee IVD waxay horeyba ugu lahaayeen joogitaan la taaban karo suuqa Shiinaha waxayna matalaan caqabadaha suurtagalka ah ee tartanka soo galaya suuqa.Ciyaartoyda muhiimka ah waxaa ka mid ah Roche Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories, Danaher Corporation, iyo bioMerieux SA.
Shirkaduhu waxay ku raaxaystaan ilo dhaqaale oo aad u weyn si ay u awoodaan kharashyada la xidhiidha shahaadaynta alaabta, tijaabooyinka caafimaad, iyo matalaadda wakiilka.Intaa waxaa dheer, shirkadahani waxay samayn karaan iibsiyada lagama maarmaanka ah si loo dhiso qaybinta tooska ah iyo hawlaha wax soo saarka gudaha.
Qaybaha Dabool
Suuqa Kiimikada Clinical
Immunoassay Market
Suuqa ogaanshaha Molecular
Suuqa Microbiology
Suuqa Hematology
Is-ilaalinta Suuqa Gulukooska Dhiiga (SMBG).
Goobta Imtixaanka Daryeelka (POCT) Suuqa
Suuqa xinjirowga
Waqtiga boostada: Mar-11-2022